Part 1. DHA, its usefulness in humans, and its configuration in the form of triglyceride
Multimedia
Brudy’s DHA
Part 2. Brudy’s DHA triglyceride synthesis process
Part 3. Brudy’s DHA triglyceride antioxidant effect
Glaucoma
The benefits of supplementing with DHA triglyceride and antioxidants in pesudoexfoliative glaucoma
Effects of tridocosahexanoin-Aox® on the expression of inflammatory mediators in the year of glaucoma patients affected with dry eye
Ocular surface
DHA triglyceride in Meibomian gland dysfunction placebo-controlled double-blind study
Effects of tridocosahexanoin-Aox® on the expression of inflammatory mediators in the tear of patients affected with dry eye
Antioxidant and antiinflammatory activity of DHA-triglyceride in Keratokonus affected patients
Retina
The hoint administration of DHA triglyceride and lutein intensifies the optical density of the macular pigment
Three-year results of oral supplementation with DHA triglyceride and antioxidants in diabetic macular edema treated with intravitreal Ranibizumab
Influence of DHA triglyceride on macular sensitivity in non-proliferative diabetic retinopathy measures with microperimetry
Eye inflammation
Effects of tridocosahexanoin-Aox® on the expression of inflammatory mediators in non-infectious anterior uveitis
Hepatology
Preclinical model study of rats with advanced liver disease treated with DHA triglyceride versus placebo
Cell cultures
Brudy’s DHA triglyceride inhibits the nuclear-kß factor(FN-KB) and the syntesis of cytokines in microglias BV2
Breastfeeding
Inadequate content of docosahexanoic acid (DHA) of donor human milk for feeding preterm infants
Inadequate proportion of polyunsaturated fatty acids in the erythrocyte membrane of premature newborns during the first month of life: differences with those born at term
Cystic fibrosis
Double-blind, placebo-controlled study on the effects of DHA triglyceride supplementation on the erythrocyte membrane of children affected by Cystic Fibrosis (N=22)